- Chevron Corp (CVX) Reports Profit of $201 million in third quarter 2020
- Overstock.com, Inc. (OSTK) Stumbles After Reported Q3 2020 Financial Results
- What's the Analyst Recommendation for Rekor Systems Inc. (REKR)?
- Let’s Take a Look at Bunge Limited (BG) Stock
- Is it Time to Sell/Buy Callaway Golf Company (ELY) Stock After Recent Trade?
Akebia Therapeutics Inc. (AKBA) share price soared 6.75% with the closing price of $3.32 on Monday. Akebia Therapeutics Inc. stock has an exchanging volume of 15.21 million shares, which is high, contrasted with its 3-months average volume of 5.12M shares. Its market capitalization has now reached to $444.85M.
Akebia to Present Global Phase 3 Vadadustat Data at American Society of Nephrology Kidney Week 2020 Reimagined on October 9, 2020 news published at Yahoo.
AKBA Past Trading Activity
The market tends to become urbane often, in any event, for prepared investors and traders. In any event, when a merchant got what he/she had expected, the market occasionally chooses to move the other way. This instability leads a few traders questioning and re-thinking their moves. This is the reason becoming acquainted with past price performance, just as both long and short time period, is significant. If we look the past performance, during the last one week, AKBA price has rose by 23.42%. In the course of past three months sees the stock go down around -72.12%, while it has lost -55.50% over the past six months and -47.47% since the start of the year.
AKBA Earning History
Earnings per share are the amount of profit that a company produces during a specific period, which is usually defined as a quarter (three calendar months) or a year. In recent quarter of (Sep 2020), the firm recorded a revenue of 90.14 billion, which was higher than the gauge of 84.9M made by certain experts. For that equivalent quarter, Akebia Therapeutics Inc. posted -$1.28 earnings per share (EPS) which was underneath the consensus estimate of -$0.5 by -$0.78, which represents to a reduction by -156.00%.
AKBA Price Performance
Let us presently take a gander at a portion of its probable help and opposition resistance. Late research on Akebia Therapeutics Inc. has seen its stock exchanging -74.74% underneath its three-month high price. A glance at the opposite side additionally observes stock exchanging +41.88% above its three-month low. A more extensive look sees AKBA exchanging -75.78% beneath its 52-week high and 41.88% above from its 52-week low price.
AKBA Instability & Beta Factor
The Volatility of a stock means that the stock’s drop or increase in the event that the more extensive market drops or rushes. A beta score higher than 1 implies that a stock is profoundly unpredictable while underneath 1 implies that the Volatility of a stock is low. If we look trading Volatility. Its 7-day Volatility is around 8.03%, while it has a month to month instability of 7.56%. The company has an ATR (Average True Range) of 0.40 and a beta factor of 1.81.